Dr Anuj A Parikh, MD in Chattanooga, TN - Medicare Emergency Medicine

Dr Anuj A Parikh, MD is a medicare enrolled "Emergency Medicine" physician in Chattanooga, Tennessee. He went to Jefferson Medical College Of Thomas Jefferson University and graduated in 2002 and has 22 years of diverse experience with area of expertise as Emergency Medicine. He is a member of the group practice Doctors For Emergency Service and his current practice location is 975 E 3rd St, Chattanooga, Tennessee. You can reach out to his office (for appointments etc.) via phone at (423) 778-7296.

Dr Anuj A Parikh is licensed to practice in Tennessee (license number 39636) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1366482465.

Contact Information

	Dr Anuj A Parikh, MD
	975 E 3rd St, Chattanooga, TN 37403-2103
	(423) 778-7296
	(423) 778-8068

Physician's Profile

Full Name	Dr Anuj A Parikh
Gender	Male
Speciality	Emergency Medicine
Experience	22 Years
Location	975 E 3rd St, Chattanooga, Tennessee
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Anuj A Parikh attended and graduated from Jefferson Medical College Of Thomas Jefferson University in 2002

NPI Data:

NPI Number: 1366482465
Provider Enumeration Date: 06/07/2006
Last Update Date: 07/09/2007

Medicare PECOS Information:

PECOS PAC ID: 5496787616
Enrollment ID: I20210720003494

Medical Identifiers

Medical identifiers for Dr Anuj A Parikh such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1366482465	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207P00000X	Emergency Medicine	39636 (Tennessee)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Christiana Hospital	Newark, DE	Hospital
Union Hospital Of Cecil County	Elkton, MD	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Doctors For Emergency Service	0648160341	32

News Archive

FDA provides QIDP designation to Debiopharm's Debio 1450 for treatment of ABSSSI

Debiopharm Group™(Debiopharm), a Swiss-based global biopharmaceutical company developing prescription drugs that target unmet medical needs including anti-infective and oncology therapeutics as well as companion diagnostics, today announced that the US Food and Drug Administration (FDA) has designated its anti-infectious agent Debio 1450 as a Qualified Infectious Disease Product (QIDP) for the treatment of acute bacterial skin and skin structure infections (ABSSSI).

MedStar NRH, Georgetown University create new Center for Brain Plasticity and Recovery

Georgetown University and MedStar National Rehabilitation Network announced today a new research and patient care partnership that extends the boundaries of neuroscience. The new Center for Brain Plasticity and Recovery marks the launch of a rare research continuum spanning basic and translational science in brain recovery.

International Stem Cell, IBVI sign letter of intent concerning funding, establishment of ISCO India

International Stem Cell Corporation, www.internationalstemcell.com, and Insight Bioventures India Private Limited, announced today that they have signed a letter of intent concerning funding and establishment of an Indian affiliate of ISCO. The goal is to establish world-class development and manufacturing operations for ISCO's research and pharmaceutical products in India, including its Lifeline Cell Technology research products and human corneal tissue, CytoCor, for treatment of corneal vision impairment and testing of chemicals.

Baxter International, DVC present Phase III clinical efficacy data for PREFLUCEL

Baxter International Inc., in conjunction with DynPort Vaccine Company LLC, a CSC Company, today presented Phase III study data measuring the clinical efficacy for PREFLUCEL, a trivalent seasonal influenza candidate vaccine. PREFLUCEL is made using Baxter's Vero cell culture platform and does not contain an adjuvant or preservatives. The data were presented at the International Congress on Infectious Disease (ICID) in Miami, Florida.

JDRF, KalVista collaborate to focus on novel approach for diabetic macular edema

KalVista Pharmaceuticals and JDRF have formed a research partnership focused on a novel approach being developed by KalVista to preserve vision and slow the progression of diabetic eye disease.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Anuj A Parikh allows following entities to bill medicare on his behalf.

Entity Name	Doctors For Emergency Service
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1750369674 PECOS PAC ID: 0648160341 Enrollment ID: O20210625000768

News Archive

FDA provides QIDP designation to Debiopharm's Debio 1450 for treatment of ABSSSI

MedStar NRH, Georgetown University create new Center for Brain Plasticity and Recovery

International Stem Cell, IBVI sign letter of intent concerning funding, establishment of ISCO India

Baxter International, DVC present Phase III clinical efficacy data for PREFLUCEL

JDRF, KalVista collaborate to focus on novel approach for diabetic macular edema

KalVista Pharmaceuticals and JDRF have formed a research partnership focused on a novel approach being developed by KalVista to preserve vision and slow the progression of diabetic eye disease.

Entity Name	Christiana Care Emergency Physicians Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1871375899 PECOS PAC ID: 8022468057 Enrollment ID: O20240103001008

FDA provides QIDP designation to Debiopharm's Debio 1450 for treatment of ABSSSI

MedStar NRH, Georgetown University create new Center for Brain Plasticity and Recovery

International Stem Cell, IBVI sign letter of intent concerning funding, establishment of ISCO India

Baxter International, DVC present Phase III clinical efficacy data for PREFLUCEL

JDRF, KalVista collaborate to focus on novel approach for diabetic macular edema

KalVista Pharmaceuticals and JDRF have formed a research partnership focused on a novel approach being developed by KalVista to preserve vision and slow the progression of diabetic eye disease.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Anuj A Parikh is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Anuj A Parikh, MD 724 Sunset Mountain Dr, Chattanooga, TN 37421-2075 Ph: (423) 894-0941	Dr Anuj A Parikh, MD 975 E 3rd St, Chattanooga, TN 37403-2103 Ph: (423) 778-7296

News Archive

FDA provides QIDP designation to Debiopharm's Debio 1450 for treatment of ABSSSI

MedStar NRH, Georgetown University create new Center for Brain Plasticity and Recovery

International Stem Cell, IBVI sign letter of intent concerning funding, establishment of ISCO India

Baxter International, DVC present Phase III clinical efficacy data for PREFLUCEL

JDRF, KalVista collaborate to focus on novel approach for diabetic macular edema

KalVista Pharmaceuticals and JDRF have formed a research partnership focused on a novel approach being developed by KalVista to preserve vision and slow the progression of diabetic eye disease.

Emergency Medicine Doctors in Chattanooga, TN

Joseph Kerby Gray, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 2525 De Sales Ave, Chattanooga, TN 37404 Phone: 423-495-2525
Ronald A. Gracy Ii, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 941 Spring Creek Rd, Chattanooga, TN 37412 Phone: 423-894-7870 Fax: 865-539-8008
Dr. Jocelyn May De Guzman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1755 Gunbarrel Rd, Chattanooga, TN 37421 Phone: 423-680-8534
Dr. Jeffrey Durant Clinkscales, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-7628
Dr. Shelley L Murphy, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1018 Blackford Street, Chattanooga, TN 37403 Phone: 423-778-7000
Samuel Wilson, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2525 Desales Ave, Chattanooga, TN 37404 Phone: 423-697-0014 Fax: 423-648-6280
Dr. James B Bardoner, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-7296 Fax: 423-778-8086

Dr Anuj A Parikh, MD - Medicare Emergency Medicine in Chattanooga, TN

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

FDA provides QIDP designation to Debiopharm's Debio 1450 for treatment of ABSSSI

MedStar NRH, Georgetown University create new Center for Brain Plasticity and Recovery

International Stem Cell, IBVI sign letter of intent concerning funding, establishment of ISCO India

Baxter International, DVC present Phase III clinical efficacy data for PREFLUCEL

JDRF, KalVista collaborate to focus on novel approach for diabetic macular edema

Medicare Reassignments

FDA provides QIDP designation to Debiopharm's Debio 1450 for treatment of ABSSSI

MedStar NRH, Georgetown University create new Center for Brain Plasticity and Recovery

International Stem Cell, IBVI sign letter of intent concerning funding, establishment of ISCO India

Baxter International, DVC present Phase III clinical efficacy data for PREFLUCEL

JDRF, KalVista collaborate to focus on novel approach for diabetic macular edema

FDA provides QIDP designation to Debiopharm's Debio 1450 for treatment of ABSSSI

MedStar NRH, Georgetown University create new Center for Brain Plasticity and Recovery

International Stem Cell, IBVI sign letter of intent concerning funding, establishment of ISCO India

Baxter International, DVC present Phase III clinical efficacy data for PREFLUCEL

JDRF, KalVista collaborate to focus on novel approach for diabetic macular edema

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

FDA provides QIDP designation to Debiopharm's Debio 1450 for treatment of ABSSSI

MedStar NRH, Georgetown University create new Center for Brain Plasticity and Recovery

International Stem Cell, IBVI sign letter of intent concerning funding, establishment of ISCO India

Baxter International, DVC present Phase III clinical efficacy data for PREFLUCEL

JDRF, KalVista collaborate to focus on novel approach for diabetic macular edema

Emergency Medicine Doctors in Chattanooga, TN